Renal artery perfusion modifies ischemia/reperfusion injury

J. D. Hughes, Samer Mattar, C. Chen, A. Someren, B. Noe, C. R. Suwyn, A. B. Lumsden

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Renal ischemic and reperfusion injury is a significant complication of major aortic and renovascular surgery. The delivery of a preservative agent just prior to reperfusion of an ischemic kidney may decrease the reperfusion injury. The purpose of this study was to evaluate the effects of renal artery perfusates delivered at the termination of an ischemic period. Five groups of rats were evaluated. All rats underwent left nephrectomy. The right kidney was made ischemic for 45 min by occlusion of the renal artery and vein. Ischemic control animals had no renal artery perfusion. Nonischemic control animals had no renal vessel occlusion or perfusion. The other three groups were perfused during the final 4 min of ischemia with one of the following: normal saline (NS), phosphate-buffered saline (PBS), or anti-ICAM-1-antibody (mAb). The blood urea nitrogen (BUN), serum creatinine (Cr), and renal histopathologic injury of each group were compared. The ischemic control group had significantly better renal function than the group perfused with NS or mAb at 72 hr. There was no significant difference between the ischemic control and PBS groups in renal function or morphologic injury. It is concluded that none of the perfusates in the study had protected the kidney from ischemic and reperfusion injury. NS delivered in this manner was injurious to the kidney.

Original languageEnglish (US)
Pages (from-to)321-326
Number of pages6
JournalJournal of Surgical Research
Volume60
Issue number2
DOIs
StatePublished - Feb 1 1996
Externally publishedYes

Fingerprint

Renal Artery
Reperfusion Injury
Perfusion
Kidney
Phosphates
Renal Veins
Blood Urea Nitrogen
Wounds and Injuries
Intercellular Adhesion Molecule-1
Nephrectomy
Reperfusion
Creatinine
Ischemia
Control Groups
Antibodies
Serum

ASJC Scopus subject areas

  • Surgery

Cite this

Hughes, J. D., Mattar, S., Chen, C., Someren, A., Noe, B., Suwyn, C. R., & Lumsden, A. B. (1996). Renal artery perfusion modifies ischemia/reperfusion injury. Journal of Surgical Research, 60(2), 321-326. https://doi.org/10.1006/jsre.1996.0051

Renal artery perfusion modifies ischemia/reperfusion injury. / Hughes, J. D.; Mattar, Samer; Chen, C.; Someren, A.; Noe, B.; Suwyn, C. R.; Lumsden, A. B.

In: Journal of Surgical Research, Vol. 60, No. 2, 01.02.1996, p. 321-326.

Research output: Contribution to journalArticle

Hughes, JD, Mattar, S, Chen, C, Someren, A, Noe, B, Suwyn, CR & Lumsden, AB 1996, 'Renal artery perfusion modifies ischemia/reperfusion injury', Journal of Surgical Research, vol. 60, no. 2, pp. 321-326. https://doi.org/10.1006/jsre.1996.0051
Hughes JD, Mattar S, Chen C, Someren A, Noe B, Suwyn CR et al. Renal artery perfusion modifies ischemia/reperfusion injury. Journal of Surgical Research. 1996 Feb 1;60(2):321-326. https://doi.org/10.1006/jsre.1996.0051
Hughes, J. D. ; Mattar, Samer ; Chen, C. ; Someren, A. ; Noe, B. ; Suwyn, C. R. ; Lumsden, A. B. / Renal artery perfusion modifies ischemia/reperfusion injury. In: Journal of Surgical Research. 1996 ; Vol. 60, No. 2. pp. 321-326.
@article{414cbbc1635444949eaf438f0687a8ce,
title = "Renal artery perfusion modifies ischemia/reperfusion injury",
abstract = "Renal ischemic and reperfusion injury is a significant complication of major aortic and renovascular surgery. The delivery of a preservative agent just prior to reperfusion of an ischemic kidney may decrease the reperfusion injury. The purpose of this study was to evaluate the effects of renal artery perfusates delivered at the termination of an ischemic period. Five groups of rats were evaluated. All rats underwent left nephrectomy. The right kidney was made ischemic for 45 min by occlusion of the renal artery and vein. Ischemic control animals had no renal artery perfusion. Nonischemic control animals had no renal vessel occlusion or perfusion. The other three groups were perfused during the final 4 min of ischemia with one of the following: normal saline (NS), phosphate-buffered saline (PBS), or anti-ICAM-1-antibody (mAb). The blood urea nitrogen (BUN), serum creatinine (Cr), and renal histopathologic injury of each group were compared. The ischemic control group had significantly better renal function than the group perfused with NS or mAb at 72 hr. There was no significant difference between the ischemic control and PBS groups in renal function or morphologic injury. It is concluded that none of the perfusates in the study had protected the kidney from ischemic and reperfusion injury. NS delivered in this manner was injurious to the kidney.",
author = "Hughes, {J. D.} and Samer Mattar and C. Chen and A. Someren and B. Noe and Suwyn, {C. R.} and Lumsden, {A. B.}",
year = "1996",
month = "2",
day = "1",
doi = "10.1006/jsre.1996.0051",
language = "English (US)",
volume = "60",
pages = "321--326",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Renal artery perfusion modifies ischemia/reperfusion injury

AU - Hughes, J. D.

AU - Mattar, Samer

AU - Chen, C.

AU - Someren, A.

AU - Noe, B.

AU - Suwyn, C. R.

AU - Lumsden, A. B.

PY - 1996/2/1

Y1 - 1996/2/1

N2 - Renal ischemic and reperfusion injury is a significant complication of major aortic and renovascular surgery. The delivery of a preservative agent just prior to reperfusion of an ischemic kidney may decrease the reperfusion injury. The purpose of this study was to evaluate the effects of renal artery perfusates delivered at the termination of an ischemic period. Five groups of rats were evaluated. All rats underwent left nephrectomy. The right kidney was made ischemic for 45 min by occlusion of the renal artery and vein. Ischemic control animals had no renal artery perfusion. Nonischemic control animals had no renal vessel occlusion or perfusion. The other three groups were perfused during the final 4 min of ischemia with one of the following: normal saline (NS), phosphate-buffered saline (PBS), or anti-ICAM-1-antibody (mAb). The blood urea nitrogen (BUN), serum creatinine (Cr), and renal histopathologic injury of each group were compared. The ischemic control group had significantly better renal function than the group perfused with NS or mAb at 72 hr. There was no significant difference between the ischemic control and PBS groups in renal function or morphologic injury. It is concluded that none of the perfusates in the study had protected the kidney from ischemic and reperfusion injury. NS delivered in this manner was injurious to the kidney.

AB - Renal ischemic and reperfusion injury is a significant complication of major aortic and renovascular surgery. The delivery of a preservative agent just prior to reperfusion of an ischemic kidney may decrease the reperfusion injury. The purpose of this study was to evaluate the effects of renal artery perfusates delivered at the termination of an ischemic period. Five groups of rats were evaluated. All rats underwent left nephrectomy. The right kidney was made ischemic for 45 min by occlusion of the renal artery and vein. Ischemic control animals had no renal artery perfusion. Nonischemic control animals had no renal vessel occlusion or perfusion. The other three groups were perfused during the final 4 min of ischemia with one of the following: normal saline (NS), phosphate-buffered saline (PBS), or anti-ICAM-1-antibody (mAb). The blood urea nitrogen (BUN), serum creatinine (Cr), and renal histopathologic injury of each group were compared. The ischemic control group had significantly better renal function than the group perfused with NS or mAb at 72 hr. There was no significant difference between the ischemic control and PBS groups in renal function or morphologic injury. It is concluded that none of the perfusates in the study had protected the kidney from ischemic and reperfusion injury. NS delivered in this manner was injurious to the kidney.

UR - http://www.scopus.com/inward/record.url?scp=0030063442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030063442&partnerID=8YFLogxK

U2 - 10.1006/jsre.1996.0051

DO - 10.1006/jsre.1996.0051

M3 - Article

C2 - 8598662

AN - SCOPUS:0030063442

VL - 60

SP - 321

EP - 326

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -